Clinical trials for Sickle cell disease

Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease

Functional Ovarian Reserve in Sickle Cell Disease

Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care

Open-Label Extension Study to Pioneer Study 6058-SCD-101

Efficacy Safety Study of Gene Therapy for Sickle Cell DiseaseSCD Using Autologous CD34+ Cells Transduced ex Vivo, Carrying a Corrected Globin Gene and a Silencing RNA.

Writing Relaxing Beats in Adolescents Who Have Sickle Cell Disease

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease

Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease

Early Screening and Treatment of Heart Complication in Sickle Cell Disease

Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0

Exploratory Study on Global Reflexology in Sickle Cell Disease

Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease

Ultrasound Acute Chest Syndrome Sickle Cell Disease

Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain

MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease

Phenotypic and Transcriptomic Description of Megakaryocytes in Sickle Cell Patient

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

Adapting the FACETS Program to Sickle Cell Disease

Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

Empowering Adolescents and Young Adults With Sickle Cell Disease as Partners in Treatment Decision Making (EMPOWER-AYA)

SCD Stem Cell Mobilization and Apheresis Using Motixafortide

Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Effect of EMDR for Reduction of Pain Interference in Children With Sickle Cell Disease

Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease

Peripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease

Virtual Reality As Adjunct Therapy for Vaso-Occlusive Pain

Clinical Study of BRL-101 in Severe SCD

Predictors of Pain in Sickle Cell Disease

Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness

Lung Ultrasound in Pediatric Acute Chest Syndrome

Molecular and Cellular Basis of Severe Forms of Dengue in Sickle Cell Patients

A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301

Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

Long-term Follow-up (LTFU) of Patients Treated With Genome-edited Autologous Hematopoietic Stem and Progenitor Cells (HSPC)

SMYLS Multi-site Trial

Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody

Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease

Acupressure in Patients With Sickle Cell Disease

Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function

Sickle Cell Children's Exercise Study (SuCCESs)

Assessing Physical Function in Sickle Cell Patients Taking Voxelotor

A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke

Effects of the Contraceptive Implant in Women With Sickle Cell Disease

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

Gene Therapy Communication: Use of a Needs Assessment to Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX)

Tocilizumab for Acute Chest Syndrome

Effect of NUV001 Supplementation in Patients Suffering From Sickle Cell Disease (SCD)

RElated Haplo-DonoR Haematopoietic stEm Cell Transplantation for Adults With Severe Sickle Cell Disease

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Arterial Function Parameters and Transcranial Doppler Velocity in Paediatric Patients With Sickle Cell Disease

A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease

CHOICES3: Sickle Cell Disease Parenting CHOICES

Lipid Balance in Adult Sickle Cell Patients

PET Imaging of Vaso-Occlusive Crisis (VOC) in SCD

Synthetic Generation of Hematological Data Over Federated Computing Frameworks: SCD Use Case

Study of the Role of Genetic Modifiers in Hemoglobinopathies

BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease

TMLI and Alemtuzumab for Treatment of Sickle Cell Disease

Cooperative Assessment of Late Effects for SCD Curative Therapies

A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001)

Cognitive Remediation Intervention to Prepare for Transition of Care

Alternative Dosing And Prevention of Transfusions (ADAPT)

Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease

Sickle Cell Disease Obstetric Multi-Disciplinary Care Programme

A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)

Cutaneous Hydration Assessment in SCD

RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)

Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease

Integrative Medicine in Pain Management in Sickle Cell Disease

A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY)

A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease

The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.

Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat

Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapy

An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease

ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study

High-flow Oxygen for Vaso-occlusive Pain Crisis

Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)

A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease

A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease

Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell Transplantation

A Blood Stem Cell Transplant for Sickle Cell Disease

Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA)

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

Gene Transfer for Sickle Cell Disease

Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease

Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Sickle-cell Disease Registry of the GPOH

Identifying Barriers and Strategies to Support Self-efficacy for Medication Adherence With Text Messaging

Glucose Metabolism in Sickle Cell Disease

Sickle Cell Hemoglobinopathies and Bone Health